A/Prof Mary Ann Anderson
Honorary Conjoint Principal Fellow
The Sir Peter MacCallum Department of Oncology
177 Scholarly works
1 Projects
HIGHLIGHTS
2022
Journal article
Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapy
DOI: 10.1182/blood.20220160402022
Journal article
Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL
DOI: 10.1182/blood.20210127752022
Research grants (other domestic)
Novel Strategies to Predict and Monitor Response to CAR T-Cell Therapy in DLBCL
2021
Journal article
Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition
DOI: 10.1182/bloodadvances.20210050832021
Journal article
Efficacy of venetoclax plus rituximab for relapsed CLL: 5-year follow-up of continuous or limited- duration therapy
DOI: 10.1182/blood.20200095782020
Journal article
BAX-Mutated Clonal Hematopoiesis in Patients on Long-Term Venetoclax for Relapsed/Refractory Chronic Lymphocytic Leukemia
DOI: 10.1182/blood-2020-1377752020
Journal article
Multiple BCL2 mutations cooccurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax
DOI: 10.1182/BLOOD.2019004205
RECENT SCHOLARLY WORKS
2026
Journal article
Venetoclax Retreatment in Chronic Lymphocytic Leukemia is biologically rational and clinically effective.
DOI: 10.1182/bloodadvances.20260198712026
Journal article
Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma
DOI: 10.1182/bloodadvances.20250166462026
Journal article
Zanubrutinib for the treatment of patients with del(17p) and/or TP53 CLL/SLL: analysis across clinical studies
DOI: 10.1182/bloodadvances.20250159862026
Journal article
Central nervous system involvement in CLL: an international retrospective study by ERIC, the European Research Initiative on CLL
DOI: 10.1182/bloodadvances.20250177552026
Journal article
Optimizing Control Arms in Chronic Lymphocytic Leukemia Clinical Trials: The BRUIN-CLL-321 Trial
DOI: 10.1200/JCO-25-016952026
Journal article
Neurological implications of chimeric antigen receptor-T cell therapy
DOI: 10.1136/bmjno-2025-0014912025
Journal article
Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial
DOI: 10.1093/infdis/jiaf2972025
Journal article
Retreatment with venetoclax and rituximab following disease progression while off therapy in patients with chronic lymphocytic leukemia
DOI: 10.1002/hem3.70284